Eliminating the antilipolytic adenosine A1receptor does not lead to compensatory changes in the antilipolytic actions of PGE2and nicotinic acid
- 1 May 2007
- journal article
- Published by Wiley in Acta Physiologica
- Vol. 190 (1), 87-96
- https://doi.org/10.1111/j.1365-201x.2007.01692.x
Abstract
We examined whether compensatory changes after adenosine A(1) receptor knockout [A(1)R (-/-)] eliminate the antilipolytic actions mediated by this receptor. Lipolysis experiments were performed on adipocytes prepared from the wild type A(1)R (+/+), A(1)R (-/-) and heterozygous mice. Gene expression was assayed with cDNA microarray technique and real-time PCR; protein expression with immunoblotting. The A(1)R was the only adenosine receptor involved in lipolysis. The effects of adenosine deaminase and 2-chloroadenosine were abolished in A(1)R (-/-) mice. The IC(50) value of 2-chloroadenosine doubled from 16.6 to 33.6 nm when half of the A(1)Rs were eliminated. Adrenergic alpha(2) agonists had no effects on lipolysis. Prostaglandin E(2) (PGE(2)) inhibited lipolysis with an IC(50) value of 5.8 nm (4.7-7.2 nm) in the A(1)R (+/+) mice and 10.6 nm (9.0-12.6 nm) in the A(1)R (-/-) mice. Nicotinic acid inhibited lipolysis with an IC(50) value of 0.30 microm (0.19-0.46 microm) in the A(1)R (+/+) mice and 0.24 microm (0.16-0.37 microm) in the A(1)R (-/-) mice. G(i)alpha(1) mRNA was significantly up-regulated in adipose tissue from A(1)R (-/-) mice. However, immunoblotting showed that G(ialpha1) was not up-regulated at the protein level. The A(1)R mediates the antilipolytic actions of adenosine. Deletion of the A(1)R in mice does not result in compensatory increases in G-protein-mediated antilipolytic actions of PGE(2) or nicotinic acid.Keywords
This publication has 35 references indexed in Scilit:
- The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic targetTrends in Pharmacological Sciences, 2006
- Signalling mechanisms regulating lipolysisCellular Signalling, 2006
- Human fat cell lipolysis: Biochemistry, regulation and clinical roleBest Practice & Research Clinical Endocrinology & Metabolism, 2005
- Molecular Identification of High and Low Affinity Receptors for Nicotinic AcidJournal of Biological Chemistry, 2003
- Coffee consumption and risk of type 2 diabetes mellitusThe Lancet, 2002
- Human alpha 2A-adrenergic receptor gene expressed in transgenic mouse adipose tissue under the control of its regulatory elementsJournal of Molecular Endocrinology, 2002
- The Use of Genetic “Knockout” Mice in Behavioral Endocrinology ResearchHormones and Behavior, 1997
- Changes in adenosine A1- and A2-receptor expression during adipose cell differentiationMolecular and Cellular Endocrinology, 1996
- Coupling of inhibitory receptors with Gi-proteins in hamster adipocytes: comparison between adenosine A1 receptor and α2-adrenoceptorEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Facilitation by Adenosine of the Action of Insulin on the Accumulation of Adenosine 3′:5′‐Monophosphate, Lipolysis, and Glucose Oxidation in Isolated Fat CellsEuropean Journal of Biochemistry, 1974